Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.560
-0.070 (-2.66%)
At close: Nov 26, 2025, 4:00 PM EST
2.590
+0.030 (1.17%)
After-hours: Nov 26, 2025, 5:41 PM EST
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $20.46 million as of November 26, 2025. Its market cap has increased by 27.03% in one year.
Market Cap
20.46M
Enterprise Value
14.04M
1-Year Change
27.03%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $20.46M, a decrease of -95.00%. That is a compound annual growth rate of -21.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 21.02M | -34.87% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | 86.15M | 123.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 974.34B |
| Johnson & Johnson | 499.23B |
| AbbVie | 411.71B |
| UnitedHealth Group | 295.44B |
| AstraZeneca | 283.06B |
| Merck & Co. | 257.09B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 222.45B |